Press Release – New York, NY – May 3rd, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it has represented A.G.P/ Alliance Global Partners (through Euro Pacific Capital) as sole book running manager in the underwritten public offering of shares of Common Stock of Cocrystal Pharma, Inc. (NASDAQ: COCP). Cocrystal sold an aggregate of 4,210,527 shares of Common Stock at a price of $1.90 per share. Cocrystal is a clinical stage biotechnology company seeking to discover and develop novel antiviral therapeutics as treatments for serious and/or chronic viral diseases. The Sichenzia Ross Ference Kesner LLP team was led by partners Marc Ross, Avital Perlman and Tom Rose.
Latest posts by Sichenzia Ross Ference Carmel LLP (see all)
- Sichenzia Ross Ference Carmel 任命 Matilde Tysz 为首席战略官 - April 9, 2025
- Kleidman, Carl - April 8, 2025
- Sichenzia Ross Ference Carmel LLP 代表 ThinkEquity 参与 Perfect Moment Ltd. 的 640 万美元私募。 - April 8, 2025